|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Tammenoms Bakker Juliet
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-11-02 Purchase |
2018-11-02 7:28 pm |
Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director, 10% Owner |
533,333 | $15 | $7,999,995 | 2,933,333 (Indirect) |
View |
| 2018-09-21 Purchase |
2018-09-25 4:43 pm |
Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
365,000 | $5.5 | $2,007,500 | 3,261,535 (Indirect) |
View |
| 2018-07-02 Purchase |
2018-07-02 9:16 pm |
Tricida Inc. | TCDA | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
131,579 | $19 | $2,500,001 | 3,019,734 (Indirect) |
View |
| 2018-06-25 Purchase |
2018-06-26 4:55 pm |
Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
150,000 | $16 | $2,400,000 | 3,190,079 (Indirect) |
View |
| 2018-02-22 Purchase |
2018-02-26 4:25 pm |
Aimmune Therapeutics Inc. | AIMT | Tammenoms Bakker Juliet 10% Owner |
9,375 | $32 | $300,000 | 6,013,134 (Indirect Direct) |
View |
| 2017-12-08 Sale |
2017-12-12 4:20 pm |
COLLEGIUM PHARMACEUTICAL INC | COLL | Longitude Capital Partners LLC Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Capital Associates L.P. Longitude Venture Partners L.P. 10% Owner |
1,000,000 | $17.34 | $17,340,000 | 2,276,222 (Indirect) |
View |
| 2017-07-25 Purchase |
2017-07-27 5:23 pm |
Kala Pharmaceuticals Inc. | KALA | Longitude Capital Partners II LLC ENRIGHT PATRICK G Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
215,000 | $15 | $3,225,000 | 2,270,946 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-27 Option Award |
2019-07-01 7:27 pm |
N/A N/A |
Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director, 10% Owner |
1,667 | $0 | 2,933,333 (Direct) |
View |
| 2019-06-27 Option Award |
2019-07-01 7:27 pm |
N/A 2029-06-27 |
Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director, 10% Owner |
5,000 | $37.15 | 2,933,333 (Direct) |
View |
| 2018-12-06 Option Award |
2018-12-10 9:17 pm |
N/A N/A |
Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director, 10% Owner |
2,500 | $0 | 2,933,333 (Direct) |
View |
| 2018-12-06 Option Award |
2018-12-10 9:17 pm |
N/A 2028-12-06 |
Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director, 10% Owner |
5,000 | $14.8 | 2,933,333 (Direct) |
View |
| 2018-11-02 Conversion |
2018-11-02 7:28 pm |
N/A N/A |
Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director, 10% Owner |
2,400,000 | $0 | 2,933,333 (Indirect) |
View |
| 2018-11-02 Conversion |
2018-11-02 7:28 pm |
N/A N/A |
Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director, 10% Owner |
2,000,000 | $0 | 2,933,333 (Indirect) |
View |
| 2018-07-02 Conversion |
2018-07-02 9:16 pm |
N/A N/A |
Tricida Inc. | TCDA | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
2,431,511 | $0 | 3,019,734 (Indirect) |
View |
| 2018-07-02 Conversion |
2018-07-02 9:16 pm |
N/A N/A |
Tricida Inc. | TCDA | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
456,644 | $0 | 3,019,734 (Indirect) |
View |
| 2018-07-02 Conversion |
2018-07-02 9:16 pm |
N/A N/A |
Tricida Inc. | TCDA | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
9,677,419 | $0 | 3,019,734 (Indirect) |
View |
| 2018-07-02 Conversion |
2018-07-02 9:16 pm |
N/A N/A |
Tricida Inc. | TCDA | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
1,817,447 | $0 | 3,019,734 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-26 4:55 pm |
N/A N/A |
Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
1,047,450 | $0 | 3,190,079 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-26 4:55 pm |
N/A N/A |
Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
1,197,076 | $0 | 3,190,079 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-26 4:55 pm |
N/A N/A |
Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
795,553 | $0 | 3,190,079 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-26 4:55 pm |
N/A N/A |
Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
28,895,188 | $0 | 3,190,079 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-26 4:55 pm |
N/A N/A |
Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
33,022,786 | $0 | 3,190,079 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-26 4:55 pm |
N/A N/A |
Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
21,946,300 | $0 | 3,190,079 (Indirect) |
View |
| 2017-07-25 Conversion |
2017-07-27 5:23 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Longitude Capital Partners II LLC ENRIGHT PATRICK G Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
2,055,946 | $0 | 2,270,946 (Indirect) |
View |
| 2017-07-25 Conversion |
2017-07-27 5:23 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Longitude Capital Partners II LLC ENRIGHT PATRICK G Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner |
10,707,985 | $0 | 2,270,946 (Indirect) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Fri, 19 Jul 2019 07:57:14 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |